Calcium content of St. Thomas' II cardioplegic solution damages ischemic immature myocardium.
Clinical application of hypothermic pharmacologic cardioplegia in pediatric cardiac surgery is less than satisfactory, despite its well known benefits in adults. Protection of the ischemic immature rabbit heart with hypothermia alone is better than with hypothermic St. Thomas' II cardioplegic solution. Control of cellular calcium is a critical component of cardioplegic protection. We determined whether the existing calcium content of St. Thomas' II solution (1.2 mmol/L) is responsible for suboptimal protection of the ischemic immature rabbit heart. Modified hypothermic St. Thomas' II solutions (calcium content, 0 to 2.4 mmol/L) were compared with hypothermic Krebs bicarbonate buffer in protecting ischemic immature (7- to 10-day-old) hearts. Hearts (n = 6 per group) underwent aerobic "working" perfusion with Krebs buffer, and cardiac function was measured. The hearts were then arrested with a 3-minute infusion of either cold (14 degrees C) Krebs buffer (1.8 mmol calcium/L) as hypothermia alone or cold St. Thomas' II solution before 6 hours of hypothermic (14 degrees C) global ischemia. Hearts were reperfused, and postischemic enzyme leakage and recovery of function were measured. A bell-shaped dose-response profile for calcium was observed for recovery of aortic flow but not for creatine kinase leakage, with improved protection at lower calcium concentrations. Optimal myocardial protection occurred at a calcium content of 0.3 mmol/L, which was better than with hypothermia alone and standard St. Thomas' II solution. We conclude that the existing calcium content of St. Thomas' II solution is responsible, in part, for its damaging effect on the ischemic immature rabbit heart.
Baker
E J
EJ
Department of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee 53226.
Olinger
G N
GN
Baker
J E
JE
D000367:Age Factors; D000818:Animals; D001639:Bicarbonates / Q000633:toxicity; D002118:Calcium / Q000633:toxicity*; D002122:Calcium Chloride / Q000633:toxicity; D002314:Cardioplegic Solutions / Q000633:toxicity; D003402:Creatine Kinase / Q000378:metabolism; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D007036:Hypothermia, Induced; D008274:Magnesium / Q000633:toxicity; D009206:Myocardium / Q000201:enzymology; D010477:Perfusion; D011189:Potassium Chloride / Q000633:toxicity; D011817:Rabbits; D012965:Sodium Chloride / Q000633:toxicity
D001639:Bicarbonates; D002314:Cardioplegic Solutions; C041711:St. Thomas' Hospital cardioplegic solution; D012965:Sodium Chloride; D011189:Potassium Chloride; D003402:Creatine Kinase; D008274:Magnesium; D002122:Calcium Chloride; D002118:Calcium